Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage

Gene transfer allows transient or permanent genetic modifications of cells for experimental or therapeutic purposes. Gene delivery by HIV-derived lentiviral vector (LV) is highly effective but the risk of insertional mutagenesis is important and the random/uncontrollable integration of the DNA vector can deregulate the cell transcriptional activity. Non Integrative Lentiviral Vectors (NILVs) solve this issue in non-dividing cells, but they do not allow long term expression in dividing cells. In this context, obtaining stable expression while avoiding the problems inherent to unpredictable DNA vector integration requires the ability to control the integration site. One possibility is to use the integrase of phage phiC31 (phiC31-int) which catalyzes efficient site-specific recombination between the attP site in the phage genome and the chromosomal attB site of its Streptomyces host. Previous studies showed that phiC31-int is active in many eukaryotic cells, such as murine or human cells, and directs the integration of a DNA substrate into pseudo attP sites (pattP) which are homologous to the native attP site. In this study, we combined the efficiency of NILV for gene delivery and the specificity of phiC31-int for DNA substrate integration to engineer a hybrid tool for gene transfer with the aim of allowing long term expression in dividing and non-dividing cells preventing genotoxicity. We demonstrated the feasibility to target NILV integration in human and murine pattP sites with a dual NILV vectors system: one which delivers phiC31-int, the other which constitute the substrate containing an attB site in its DNA sequence. These promising results are however alleviated by the occurrence of significant DNA damages. Further improvements are thus required to prevent chromosomal rearrangements for a therapeutic use of the system. However, its use as a tool for experimental applications such as transgenesis is already applicable.

[1]  George M. Church,et al.  Heritable genome editing in C. elegans via a CRISPR-Cas9 system , 2013, Nature Methods.

[2]  J. Meredith,et al.  Next-Generation Site-Directed Transgenesis in the Malaria Vector Mosquito Anopheles gambiae: Self-Docking Strains Expressing Germline-Specific phiC31 Integrase , 2013, PloS one.

[3]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[4]  Seung Woo Cho,et al.  Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease , 2013, Nature Biotechnology.

[5]  Jeffry D. Sander,et al.  Efficient In Vivo Genome Editing Using RNA-Guided Nucleases , 2013, Nature Biotechnology.

[6]  T. Cathomen,et al.  Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells , 2012, Nucleic acids research.

[7]  B. Raymond,et al.  Efficacy and site-specificity of adenoviral vector integration mediated by the phage φC31 integrase. , 2012, Human gene therapy methods.

[8]  D. Voytas,et al.  Efficient TALEN-mediated gene knockout in livestock , 2012, Proceedings of the National Academy of Sciences.

[9]  J. Voorberg,et al.  Long-term expression of human coagulation factor VIII in a tolerant mouse model using the φC31 integrase system. , 2012, Human gene therapy.

[10]  Elo Leung,et al.  Knockout rats generated by embryo microinjection of TALENs , 2011, Nature Biotechnology.

[11]  P. Monahan,et al.  Long-term phenotypic correction in factor IX knockout mice by using phiC31 integrase-mediated gene therapy , 2011, Gene Therapy.

[12]  J. Keith Joung,et al.  Targeted gene disruption in somatic zebrafish cells using engineered TALENs , 2011, Nature Biotechnology.

[13]  Albert J R Heck,et al.  Structural basis for CRISPR RNA-guided DNA recognition by Cascade , 2011, Nature Structural &Molecular Biology.

[14]  S. Chandrasegaran,et al.  Creating designed zinc-finger nucleases with minimal cytotoxicity. , 2011, Journal of molecular biology.

[15]  J. Mallet,et al.  Influence of insulators on transgene expression from integrating and non-integrating lentiviral vectors , 2011, Genetic vaccines and therapy.

[16]  Thomas Gaj,et al.  Directed evolution of an enhanced and highly efficient FokI cleavage domain for zinc finger nucleases. , 2010, Journal of molecular biology.

[17]  Andrew R McEwan,et al.  Site-specific recombination by phiC31 integrase and other large serine recombinases. , 2010, Biochemical Society transactions.

[18]  Matthew J. Moscou,et al.  A Simple Cipher Governs DNA Recognition by TAL Effectors , 2009, Science.

[19]  Jens Boch,et al.  Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors , 2009, Science.

[20]  F. Ghadessy,et al.  Selection of bacteriophage λ integrases with altered recombination specificity by in vitro compartmentalization , 2009, Nucleic acids research.

[21]  R. Jaenisch,et al.  Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases , 2009, Nature Biotechnology.

[22]  Ignacio Anegon,et al.  Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases , 2009, Science.

[23]  Y. Kanegae,et al.  Activities of various FLP recombinases expressed by adenovirus vectors in mammalian cells. , 2009, Journal of molecular biology.

[24]  D. Carroll,et al.  Genetic Analysis of Zinc-Finger Nuclease-Induced Gene Targeting in Drosophila , 2009, Genetics.

[25]  Z. Izsvák,et al.  Hybrid lentivirus-transposon vectors with a random integration profile in human cells. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  C. Vink,et al.  Sleeping beauty transposition from nonintegrating lentivirus. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[27]  T. Jacks,et al.  Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase , 2009, Nature Protocols.

[28]  T. Jensen,et al.  PhiC31 integrase induces a DNA damage response and chromosomal rearrangements in human adult fibroblasts , 2009, BMC biotechnology.

[29]  Shondra M. Pruett-Miller,et al.  Attenuation of Zinc Finger Nuclease Toxicity by Small-Molecule Regulation of Protein Levels , 2009, PLoS genetics.

[30]  J. Mallet,et al.  Non-integrating lentiviral vectors. , 2008, Current gene therapy.

[31]  Rafael J. Yáñez-Muñoz,et al.  Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase , 2008, BMC biotechnology.

[32]  Y. Liu,et al.  Creation of Engineered Human Embryonic Stem Cell Lines Using phiC31 Integrase , 2008, Stem cells.

[33]  T. Cathomen,et al.  Targeted genome modifications using integrase-deficient lentiviral vectors. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[34]  Luigi Naldini,et al.  Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery , 2007, Nature Biotechnology.

[35]  R. Nusse,et al.  Creating transgenic Drosophila by microinjecting the site-specific φC31 integrase mRNA and a transgene-containing donor plasmid , 2007, Nature Protocols.

[36]  R. Maeda,et al.  An optimized transgenesis system for Drosophila using germ-line-specific φC31 integrases , 2007, Proceedings of the National Academy of Sciences.

[37]  D. Šuput,et al.  Overexpression of caspase-9 triggers its activation and apoptosis in vitro. , 2006, Croatian medical journal.

[38]  J. Mallet,et al.  Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo , 2006, Proceedings of the National Academy of Sciences.

[39]  M. Kay,et al.  Molecular analysis of chromosomal rearrangements in mammalian cells after phiC31-mediated integration. , 2006, Human gene therapy.

[40]  Dana Carroll,et al.  Induction and repair of zinc-finger nuclease-targeted double-strand breaks in Caenorhabditis elegans somatic cells , 2006, Proceedings of the National Academy of Sciences.

[41]  D. L. Weeks,et al.  Using phiC31 integrase to make transgenic Xenopus laevis embryos , 2006, Nature Protocols.

[42]  Jay H. Konieczka,et al.  Evolution of variants of yeast site-specific recombinase Flp that utilize native genomic sequences as recombination target sites , 2006, Nucleic acids research.

[43]  T. Rando,et al.  Long-term increase in mVEGF164 in mouse hindlimb muscle mediated by phage phiC31 integrase after nonviral DNA delivery. , 2006, Human gene therapy.

[44]  Paul D Robbins,et al.  PhiC31 integrase mediates integration in cultured synovial cells and enhances gene expression in rabbit joints , 2006, The journal of gene medicine.

[45]  Shu-zhen Huang,et al.  Identification of pseudo attP sites for phage phiC31 integrase in bovine genome. , 2006, Biochemical and biophysical research communications.

[46]  Andrew D Griffiths,et al.  Directed evolution by in vitro compartmentalization , 2006, Nature Methods.

[47]  Eric C. Olivares,et al.  Integration specificity of phage phiC31 integrase in the human genome. , 2006, Journal of molecular biology.

[48]  S. E. Barker,et al.  Effective gene therapy with nonintegrating lentiviral vectors , 2006, Nature Medicine.

[49]  Thomas A Rando,et al.  Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[50]  D. L. Weeks,et al.  Transgenic Xenopus laevis embryos can be generated using φC31 integrase , 2005, Nature Methods.

[51]  Jeffrey C. Miller,et al.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases , 2005, Nature.

[52]  D. Vollrath,et al.  phiC31 integrase confers genomic integration and long-term transgene expression in rat retina. , 2005, Investigative ophthalmology & visual science.

[53]  Eric C. Olivares,et al.  In Vivo Correction of Murine Hereditary Tyrosinemia Type I by ϕC31 Integrase-Mediated Gene Delivery. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[54]  M. Laimer,et al.  Gene therapy of epidermolysis bullosa , 2004, Expert opinion on biological therapy.

[55]  Michele P Calos,et al.  Construction of transgenic Drosophila by using the site-specific integrase from phage phiC31. , 2004, Genetics.

[56]  Z. Izsvák,et al.  Development of hyperactive sleeping beauty transposon vectors by mutational analysis. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[57]  R. Hollis,et al.  Phage integrases for the construction and manipulation of transgenic mammals , 2003, Reproductive biology and endocrinology : RB&E.

[58]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[59]  M. Kolot,et al.  Site‐specific recombination in human cells catalyzed by the wild‐type integrase protein of coliphage HK022 , 2003, Biotechnology and bioengineering.

[60]  M. Gregory,et al.  Integration Site for Streptomyces Phage φBT1 and Development of Site-Specific Integrating Vectors , 2003, Journal of bacteriology.

[61]  Adam Bagg,et al.  Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. , 2003, Molecular genetics and metabolism.

[62]  John H. Wilson.  Pointing fingers at the limiting step in gene targeting , 2003, Nature Biotechnology.

[63]  P. Khavari,et al.  φC31 Integrase-Mediated Nonviral Genetic Correction of Junctional Epidermolysis Bullosa , 2003 .

[64]  D. Ow,et al.  Site-specific cassette exchange and germline transmission with mouse ES cells expressing φC31 integrase , 2003, Nature Biotechnology.

[65]  Eric C. Olivares,et al.  Site-specific genomic integration produces therapeutic Factor IX levels in mice , 2002, Nature Biotechnology.

[66]  Ralf Kühn,et al.  Enhanced efficiency through nuclear localization signal fusion on phage PhiC31-integrase: activity comparison with Cre and FLPe recombinase in mammalian cells. , 2002, Nucleic acids research.

[67]  Peter G Schultz,et al.  Directed evolution of the site specificity of Cre recombinase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[68]  B. Thyagarajan,et al.  Directed evolution of a recombinase for improved genomic integration at a native human sequence. , 2001, Nucleic acids research.

[69]  Eric C. Olivares,et al.  Phage R4 integrase mediates site-specific integration in human cells. , 2001, Gene.

[70]  F. Gage,et al.  Delivery of the Cre recombinase by a self-deleting lentiviral vector: Efficient gene targeting in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Eric C. Olivares,et al.  Site-Specific Genomic Integration in Mammalian Cells Mediated by Phage φC31 Integrase , 2001, Molecular and Cellular Biology.

[72]  J. Wilson,et al.  Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[73]  J. Chiba,et al.  Efficient gene activation in cultured mammalian cells mediated by FLP recombinase-expressing recombinant adenovirus. , 2001, Nucleic acids research.

[74]  S Chandrasegaran,et al.  Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. , 2000, Nucleic acids research.

[75]  Eric C. Olivares,et al.  A phage integrase directs efficient site-specific integration in human cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[76]  Tsien Jz,et al.  Behavioral genetics: subregion- and cell type-restricted gene knockout in mouse brain. , 1998, Pathologie-biologie.

[77]  J. Bitinaite,et al.  Structure of FokI has implications for DNA cleavage. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[78]  J. Bitinaite,et al.  FokI dimerization is required for DNA cleavage. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[79]  Margaret C. M. Smith,et al.  In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[80]  D. Peterson,et al.  Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors , 1997, Nature Genetics.

[81]  David J. Anderson,et al.  Subregion- and Cell Type–Restricted Gene Knockout in Mouse Brain , 1996, Cell.

[82]  R. Hammer,et al.  Sustained somatic gene inactivation by viral transfer of Cre recombinase , 1996, Nature Biotechnology.

[83]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[84]  F. Graham,et al.  Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: a molecular switch for control of gene expression , 1995, Journal of virology.

[85]  M. Wood,et al.  Adenovirus gene transfer causes inflammation in the brain , 1995, Neuroscience.

[86]  B. Kwabi-Addo,et al.  A site–directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination , 1995, Nature Genetics.

[87]  J. Marth,et al.  Tissue- and site-specific DNA recombination in transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[88]  G. Wahl,et al.  Recombinase-mediated gene activation and site-specific integration in mammalian cells. , 1991, Science.

[89]  Yoshio Kato,et al.  targeted gene knockout by direct delivery of zinc-finger nuclease proteins , 2012 .

[90]  J. Lister.  Use of phage φC31 integrase as a tool for zebrafish genome manipulation. , 2011, Methods in cell biology.

[91]  T. Cathomen,et al.  Quantification of zinc finger nuclease-associated toxicity. , 2010, Methods in molecular biology.

[92]  Miriam Scadeng,et al.  Development of a novel mouse glioma model using lentiviral vectors , 2009, Nature Medicine.

[93]  M. Kay,et al.  Somatic integration from an adenoviral hybrid vector into a hot spot in mouse liver results in persistent transgene expression levels in vivo. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[94]  M. Oshimura,et al.  Phage phiC31 integrase-mediated genomic integration of the common cytokine receptor gamma chain in human T-cell lines. , 2006, The journal of gene medicine.

[95]  T. Jensen,et al.  φc31 integrase induces chromosomal aberrations in primary human fibroblasts , 2006, Gene Therapy.

[96]  T. Jensen,et al.  390. Phage c31 Integrase Induces Chromosomal Aberrations in Primary Human Fibroblasts , 2006 .

[97]  Y. Kawaguchi,et al.  Site-specific gene integration in cultured silkworm cells mediated by φC31 integrase , 2005, Molecular Genetics and Genomics.

[98]  Eric C. Olivares,et al.  In vivo correction of murine hereditary tyrosinemia type I by phiC31 integrase-mediated gene delivery. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[99]  P. Khavari,et al.  PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa. , 2003, Human gene therapy.

[100]  Xian-Yang Zhang,et al.  LSU Digital Commons LSU Digital Commons Altering the tropism of lentiviral vectors through pseudotyping Altering the tropism of lentiviral vectors through pseudotyping , 2022 .